To validate the PHGDH/cMyc/AF9/P300 axis in clinical samples, we performed endogenous Co‐IP using PHGDH antibody and found that cMyc, AF9, and p300 were associated with PHGDH in advanced HCC (Figure S8, Supporting Information). This evidence concerns the gene MLLT3 and hepatocellular carcinoma.